We are live on ! Find out more
OPK icon

Opko Health

230 hedge funds and large institutions have $376M invested in Opko Health in 2023 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 56 increasing their positions, 60 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more call options, than puts

Call options by funds: $5.14M | Put options by funds: $2.88M

45% more capital invested

Capital invested by funds: $259M → $376M (+$117M)

20% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 25

1% more funds holding

Funds holding: 227230 (+3)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0.55% less ownership

Funds ownership: 23%22.46% (-0.55%)

7% less repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 60

Holders
230
Holders Change
+3
Holders Change %
+1.32%
% of All Funds
3.61%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
30
Increased
56
Reduced
60
Closed
25
Calls
$5.14M
Puts
$2.88M
Net Calls
+$2.25M
Net Calls Change
+$2.42M
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$85.3M -$3.51M -2,244,148 -5%
BlackRock
2
BlackRock
New York
$76M +$123K +78,515 +0.2%
State Street
3
State Street
Massachusetts
$19.8M -$2.12M -1,357,379 -13%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$19M +$519K +331,968 +4%
D.E. Shaw & Co
5
D.E. Shaw & Co
New York
$12.4M +$675K +431,454 +8%
Charles Schwab
6
Charles Schwab
California
$11.2M +$465K +297,100 +6%
Northern Trust
7
Northern Trust
Illinois
$9.67M +$896K +572,670 +15%
Millennium Management
8
Millennium Management
New York
$9.39M -$3.28M -2,094,967 -33%
OIM
9
Oracle Investment Management
Connecticut
$9.21M +$2.19M +1,399,300 +49%
Dimensional Fund Advisors
10
Dimensional Fund Advisors
Texas
$8.14M -$4.89M -3,125,757 -45%
Norges Bank
11
Norges Bank
Norway
$7.02M
N
12
Nuveen
North Carolina
$5.81M
Goldman Sachs
13
Goldman Sachs
New York
$5.73M +$372K +237,899 +10%
JP Morgan Chase
14
JP Morgan Chase
New York
$5.2M +$1.77M +1,129,821 +89%
VOYA Investment Management
15
VOYA Investment Management
Georgia
$4.58M +$870K +556,035 +36%
Deutsche Bank
16
Deutsche Bank
Germany
$3.52M -$185K -118,131 -7%
Citigroup
17
Citigroup
New York
$3.51M +$184K +117,396 +8%
Two Sigma Investments
18
Two Sigma Investments
New York
$3.46M -$516K -330,009 -17%
Bank of New York Mellon
19
Bank of New York Mellon
New York
$3.45M +$72.3K +46,219 +3%
Point72 Asset Management
20
Point72 Asset Management
Connecticut
$3.34M +$2.36M +1,507,700 +4,794%
Two Sigma Advisers
21
Two Sigma Advisers
New York
$3.12M -$560K -358,100 -20%
Morgan Stanley
22
Morgan Stanley
New York
$3.07M +$46.8K +29,920 +2%
Invesco
23
Invesco
Georgia
$2.8M +$38.7K +24,737 +2%
N
24
Numerai
California
$2.59M -$1.59M -1,016,179 -46%
Nordea Investment Management
25
Nordea Investment Management
Sweden
$2.55M -$12.7K -8,091 -0.6%

OPK Hedge Fund Activity: Q2 2023 in Review

230 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Opko Health (OPK) for Q2 2023, worth a combined $376M — up 45% from $259M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new OPK positions and 25 closed out — a net gain of 5 holders — while 56 added to existing stakes and 60 trimmed.

The largest buyer was Point72 Asset Management, adding an estimated $2.36M. The largest seller was Dimensional Fund Advisors, cutting an estimated $4.89M.

  • 230 institutional investors held Opko Health (OPK) as of Q2 2023, up from 227 in Q1 2023.
  • Funds reported $376M of Opko Health stock for Q2 2023, up 45% quarter-over-quarter.
  • 30 funds opened new Opko Health positions in Q2 2023 and 25 closed out, a net change of +5 holders.
  • The largest Opko Health buyer in Q2 2023 was Point72 Asset Management, an estimated $2.36M added.
  • The largest Opko Health seller in Q2 2023 was Dimensional Fund Advisors, an estimated $4.89M sold.

Based on aggregated 13F filings for Q2 2023.